Mid-term Evaluation of Metamorphopsia in Epiretinal Membrane Surgery
NCT ID: NCT03045367
Last Updated: 2017-02-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2015-06-22
2016-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Change of Retinally-Induced Aniseikonia in Patients With Epiretinal Membrane After Vitrectomy
NCT01901406
Outcomes Based on the Pre-operative Integrity of IS/OS Junction in Idiopathic Epimacular Membrane Surgery
NCT04158791
Epiretinal Macular Membrane and Cataract Extraction
NCT00851760
Validation of a Prognostic Score for Good Visual Recovery at One Year Following Combined Surgery for Cataract and Idiopathic Epiretinal Membrane
NCT03329976
"Cataract Surgery in Eyes With Epiretinal Membrane"
NCT03404323
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Outpatients
Phacoemulsification, intraocular lens implant, vitrectomy.
Phacoemulsification, intraocular lens implant, vitrectomy.
Cataract extraction, intraocular lens implant, vitrectomy, epiretinal membrane and inner limiting retinal membrane peeling.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Phacoemulsification, intraocular lens implant, vitrectomy.
Cataract extraction, intraocular lens implant, vitrectomy, epiretinal membrane and inner limiting retinal membrane peeling.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* visual acuity ≤ 20/40
* idiopathic epiretinal membrane
* cataract
* Amsler test positive for metamorphopsia.
Exclusion Criteria
* other ocular diseases.
55 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Clinica Oculistica dell'Università di Torino
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marco DAL VECCHIO, MD
Medical Doctor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CS/526
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.